Assure-Danam Merger: Healthcare Expansion Aheadby Mark Eisenberg 12.02.2024Assure Holdings announces merger agreement with Danam Health, creating a Nasdaq-listed entity in pharmaceutical and healthcare sectors. The merger is ...
ASICS Set to Outshine Market, Morgan Stanley Predictsby Mark Eisenberg 12.02.2024Morgan Stanley reiterates its Overweight rating on ASICS Corp, with a target price of JPY6,400. The positive outlook is driven ...
Stellantis Shifts to Tesla’s EV Charging Standardby Lilu Anderson 12.02.2024Stellantis has announced it will adopt Tesla's North American Charging Standard, solidifying Tesla's dominance in the EV charging market. This ...
TOP Financial Group’s $5M Fundraising Gamble: A Bold Move for Growthby Mark Eisenberg 12.02.2024Hong Kong-based online brokerage firm TOP Financial Group plans to raise $5 million through a registered direct offering. This move ...
Emerge Commerce: Surge in Shares Post Growth Pivotby Mark Eisenberg 12.02.2024Toronto-based ecommerce brand portfolio, Emerge Commerce, sees surge in shares after achieving positive organic revenue growth in January. Investor confidence ...
Vicinity Motor Corp.: Leading in Canada’s Electric Bus Marketby John Darbie 12.02.2024Vicinity Motor Corp. has secured a major order for electric buses, solidifying its position in Canada's market. Although facing challenges ...
Finastra and Tesselate Transform US Bank Trade Financeby Mark Eisenberg 12.02.2024Finastra and Tesselate have teamed up to launch Tegula Trade Finance as a Service, simplifying and speeding up trade finance ...
Revolutionizing Workplaces with Equitable Language: Boost Productivity & Inclusivityby Lilu Anderson 12.02.2024Language plays a critical role in driving positive change in the workplace. Companies like Salesforce and Workday are implementing inclusive ...
Greenidge Nets $6M Boost: A Turnaround Tale?by John Darbie 12.02.2024Greenidge Generation Holdings secures $6 million investment from Armistice Capital to drive growth and expand its power centers and bitcoin ...
Kintara’s REM-001: A Breakthrough in Breast Cancer Cureby Mark Eisenberg 12.02.2024Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...